LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Simionescu, Maya"
  2. AU="Feng, Yicheng"
  3. AU="Roger Le Grand"
  4. AU="Tesfalidet, Solomon"
  5. AU="Geladari, Eleni"
  6. AU="Pallabi Mustafi"
  7. AU=Mountfort Katrina
  8. AU="Horne, Patrick"
  9. AU="Mhurchu, Cliona Ni"
  10. AU="Yatoo, Ali Mohd"
  11. AU="Zhang, Zhiru"
  12. AU="Hadie Adams"
  13. AU="Gaskin, Thomas R"
  14. AU="Guo, Chong"
  15. AU="Guocan Wang"
  16. AU="Catherine Crenn-Hebert"
  17. AU="Alistar, Cristina F"
  18. AU="Makhani, Sarah S"
  19. AU="Tayyeb Pourfallah"
  20. AU="Mauad, Thais"

Suchergebnis

Treffer 1 - 10 von insgesamt 144

Suchoptionen

  1. Artikel ; Online: Professor Werner Franke, an inspired and inspiring personality. Forever young, forever friends.

    Simionescu, Maya

    Cell and tissue research

    2020  Band 379, Heft 1, Seite(n) 3–4

    Mesh-Begriff(e) Cell Biology/history ; Faculty ; History, 20th Century
    Sprache Englisch
    Erscheinungsdatum 2020-01-03
    Erscheinungsland Germany
    Dokumenttyp Biography ; Editorial ; Historical Article ; Portrait
    ZDB-ID 125067-x
    ISSN 1432-0878 ; 0302-766X
    ISSN (online) 1432-0878
    ISSN 0302-766X
    DOI 10.1007/s00441-019-03154-z
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis.

    Georgescu, Adriana / Simionescu, Maya

    International journal of molecular sciences

    2021  Band 22, Heft 11

    Abstract: Cells convey information among one another. One instrument employed to transmit data and constituents to specific (target) cells is extracellular vesicles (EVs). They originate from a variety of cells (endothelial, immune cells, platelets, mesenchymal ... ...

    Abstract Cells convey information among one another. One instrument employed to transmit data and constituents to specific (target) cells is extracellular vesicles (EVs). They originate from a variety of cells (endothelial, immune cells, platelets, mesenchymal stromal cells, etc.), and consequently, their surface characteristics and cargo vary according to the paternal cell. The cargo could be DNA, mRNA, microRNA, receptors, metabolites, cytoplasmic proteins, or pathological molecules, as a function of which EVs exert different effects upon endocytosis in recipient cells. Recently, EVs have become important participants in a variety of pathologies, including atherogenesis and coronavirus disease 2019 (COVID-19)-associated thrombosis. Herein, we summarize recent advances and some of our own results on the role of EVs in atherosclerotic cardiovascular diseases, and discuss their potential to function as signaling mediators, biomarkers and therapeutic agents. Since COVID-19 patients have a high rate of thrombotic events, a special section of the review is dedicated to the mechanism of thrombosis and the possible therapeutic potential of EVs in COVID-19-related thrombosis. Yet, EV mechanisms and their role in the transfer of information between cells in normal and pathological conditions remain to be explored.
    Mesh-Begriff(e) Atherosclerosis/metabolism ; Atherosclerosis/physiopathology ; Atherosclerosis/therapy ; Atherosclerosis/virology ; Biomarkers/metabolism ; COVID-19/complications ; COVID-19/metabolism ; COVID-19/physiopathology ; COVID-19/therapy ; Endothelial Cells/metabolism ; Extracellular Vesicles/metabolism ; Humans ; Inflammation/immunology ; Inflammation/metabolism ; Inflammation/virology ; Mesenchymal Stem Cells/metabolism ; Signal Transduction/immunology ; Thrombosis/complications ; Thrombosis/metabolism ; Thrombosis/physiopathology ; Thrombosis/virology
    Chemische Substanzen Biomarkers
    Sprache Englisch
    Erscheinungsdatum 2021-05-31
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22115967
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Anti-Inflammatory Neutrophils Reprogram Macrophages toward a Pro-Healing Phenotype with Increased Efferocytosis Capacity.

    Mihaila, Andreea Cristina / Ciortan, Letitia / Tucureanu, Monica Madalina / Simionescu, Maya / Butoi, Elena

    Cells

    2024  Band 13, Heft 3

    Abstract: Following myocardial infarction (MI), blood neutrophils quickly and extensively infiltrate the heart, where they are temporally polarized into pro-inflammatory (N1) and anti-inflammatory (N2) subpopulations. Neutrophil transmigration is rapidly followed ... ...

    Abstract Following myocardial infarction (MI), blood neutrophils quickly and extensively infiltrate the heart, where they are temporally polarized into pro-inflammatory (N1) and anti-inflammatory (N2) subpopulations. Neutrophil transmigration is rapidly followed by the accrual of macrophages (MACs), which are believed to undergo local phenotypic transformations from pro-inflammatory to pro-healing MACs that mediate inflammation resolution. We hypothesized that N2 neutrophils can reprogram MACs toward a healing phenotype with increased efferocytosis capacity. To examine this, human neutrophils isolated from healthy subjects were polarized in N1 and N2 neutrophils, and their secretome was added to human MACs derived from THP monocytes. The impact of neutrophil factors on macrophages was investigated using qPCR, ELISA, Western blot, immunofluorescence, or an efferocytosis assay. The results show that the MACs exposed to N2 neutrophil secretome exhibited (i) increased expression of the anti-inflammatory molecules
    Mesh-Begriff(e) Humans ; Neutrophils/metabolism ; Efferocytosis ; Macrophages/metabolism ; Inflammation/metabolism ; Anti-Inflammatory Agents/metabolism ; Carrier Proteins/metabolism ; Phenotype
    Chemische Substanzen Anti-Inflammatory Agents ; Carrier Proteins
    Sprache Englisch
    Erscheinungsdatum 2024-01-23
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells13030208
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Dihydrotestosterone Augments the Angiogenic and Migratory Potential of Human Endothelial Progenitor Cells by an Androgen Receptor-Dependent Mechanism.

    Popa, Mirel Adrian / Mihai, Cristina Maria / Șuică, Viorel Iulian / Antohe, Felicia / Dubey, Raghvendra K / Leeners, Brigitte / Simionescu, Maya

    International journal of molecular sciences

    2024  Band 25, Heft 9

    Abstract: Endothelial progenitor cells (EPCs) play a critical role in cardiovascular regeneration. Enhancement of their native properties would be highly beneficial to ensuring the proper functioning of the cardiovascular system. As androgens have a positive ... ...

    Abstract Endothelial progenitor cells (EPCs) play a critical role in cardiovascular regeneration. Enhancement of their native properties would be highly beneficial to ensuring the proper functioning of the cardiovascular system. As androgens have a positive effect on the cardiovascular system, we hypothesized that dihydrotestosterone (DHT) could also influence EPC-mediated repair processes. To evaluate this hypothesis, we investigated the effects of DHT on cultured human EPCs' proliferation, viability, morphology, migration, angiogenesis, gene and protein expression, and ability to integrate into cardiac tissue. The results showed that DHT at different concentrations had no cytotoxic effect on EPCs, significantly enhanced the cell proliferation and viability and induces fast, androgen-receptor-dependent formation of capillary-like structures. DHT treatment of EPCs regulated gene expression of androgen receptors and the genes and proteins involved in cell migration and angiogenesis. Importantly, DHT stimulation promoted EPC migration and the cells' ability to adhere and integrate into murine cardiac slices, suggesting it has a role in promoting tissue regeneration. Mass spectrometry analysis further highlighted the impact of DHT on EPCs' functioning. In conclusion, DHT increases the proliferation, migration, and androgen-receptor-dependent angiogenesis of EPCs; enhances the cells' secretion of key factors involved in angiogenesis; and significantly potentiates cellular integration into heart tissue. The data offer support for potential therapeutic applications of DHT in cardiovascular regeneration and repair processes.
    Mesh-Begriff(e) Dihydrotestosterone/pharmacology ; Humans ; Cell Movement/drug effects ; Receptors, Androgen/metabolism ; Neovascularization, Physiologic/drug effects ; Cell Proliferation/drug effects ; Endothelial Progenitor Cells/metabolism ; Endothelial Progenitor Cells/drug effects ; Endothelial Progenitor Cells/cytology ; Animals ; Cells, Cultured ; Mice ; Cell Survival/drug effects ; Androgens/pharmacology ; Androgens/metabolism ; Male
    Chemische Substanzen Dihydrotestosterone (08J2K08A3Y) ; Receptors, Androgen ; Androgens
    Sprache Englisch
    Erscheinungsdatum 2024-04-29
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms25094862
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Molecular Research in Cardiovascular Disease.

    Dorobantu, Maria / Simionescu, Maya / Popa-Fotea, Nicoleta-Monica

    International journal of molecular sciences

    2021  Band 22, Heft 13

    Abstract: Cardiovascular diseases have attracted our full attention not only because they are the main cause of mortality and morbidity in many countries but also because the therapy for and cure of these maladies are among the major challenges of the medicine in ... ...

    Abstract Cardiovascular diseases have attracted our full attention not only because they are the main cause of mortality and morbidity in many countries but also because the therapy for and cure of these maladies are among the major challenges of the medicine in the 21st century [...].
    Sprache Englisch
    Erscheinungsdatum 2021-07-04
    Erscheinungsland Switzerland
    Dokumenttyp Editorial
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22137199
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Aortic valve disease in diabetes: Molecular mechanisms and novel therapies.

    Manduteanu, Ileana / Simionescu, Dan / Simionescu, Agneta / Simionescu, Maya

    Journal of cellular and molecular medicine

    2021  Band 25, Heft 20, Seite(n) 9483–9495

    Abstract: Valve disease and particularly calcific aortic valve disease (CAVD) and diabetes (DM) are progressive diseases constituting a global health burden for all aging societies (Progress in Cardiovascular Diseases. 2014;56(6):565: Circulation Research. 2021; ... ...

    Abstract Valve disease and particularly calcific aortic valve disease (CAVD) and diabetes (DM) are progressive diseases constituting a global health burden for all aging societies (Progress in Cardiovascular Diseases. 2014;56(6):565: Circulation Research. 2021;128(9):1344). Compared to non-diabetic individuals (The Lancet. 2008;371(9626):1800: The American Journal of Cardiology. 1983;51(3):403: Journal of the American College of Cardiology. 2017;69(12):1523), the diabetic patients have a significantly greater propensity for cardiovascular disorders and faster degeneration of implanted bioprosthetic aortic valves. Previously, using an original experimental model, the diabetic-hyperlipemic hamsters, we have shown that the earliest alterations induced by these conditions occur at the level of the aortic valves and, with time these changes lead to calcifications and CAVD. However, there are no pharmacological treatments available to reverse or retard the progression of aortic valve disease in diabetes, despite the significant advances in the field. Therefore, it is critical to uncover the mechanisms of valve disease progression, find biomarkers for diagnosis and new targets for therapies. This review aims at presenting an update on the basic research in CAVD in the context of diabetes. We provide an insight into the accumulated data including our results on diabetes-induced progressive cell and molecular alterations in the aortic valve, new potential biomarkers to assess the evolution and therapy of the disease, advancement in targeted nanotherapies, tissue engineering and the potential use of circulating endothelial progenitor cells in CAVD.
    Mesh-Begriff(e) Animals ; Aortic Valve/metabolism ; Aortic Valve/pathology ; Aortic Valve/ultrastructure ; Atherosclerosis/etiology ; Atherosclerosis/metabolism ; Atherosclerosis/pathology ; Biomarkers ; Combined Modality Therapy ; Diabetes Complications ; Diabetes Mellitus/metabolism ; Disease Management ; Disease Susceptibility ; Endothelial Cells/metabolism ; Endothelial Cells/pathology ; Endothelial Cells/ultrastructure ; Epithelial-Mesenchymal Transition ; Extracellular Matrix/metabolism ; Heart Valve Diseases/diagnosis ; Heart Valve Diseases/etiology ; Heart Valve Diseases/metabolism ; Heart Valve Diseases/therapy ; Humans ; Hyperglycemia/complications ; Hyperglycemia/metabolism ; Inflammation Mediators/metabolism
    Chemische Substanzen Biomarkers ; Inflammation Mediators
    Sprache Englisch
    Erscheinungsdatum 2021-09-24
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2074559-X
    ISSN 1582-4934 ; 1582-4934 ; 1582-1838
    ISSN (online) 1582-4934
    ISSN 1582-4934 ; 1582-1838
    DOI 10.1111/jcmm.16937
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: Pharmacological Inhibition of Lysine-Specific Demethylase 1A Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice by a Mechanism Involving Decreased Oxidative Stress and Inflammation; Potential Implications in Human Atherosclerosis.

    Manea, Simona-Adriana / Vlad, Mihaela-Loredana / Lazar, Alexandra-Gela / Muresian, Horia / Simionescu, Maya / Manea, Adrian

    Antioxidants (Basel, Switzerland)

    2022  Band 11, Heft 12

    Abstract: Dysregulated epigenetic mechanisms promote transcriptomic and phenotypic alterations in cardiovascular diseases. The role of histone methylation-related pathways in atherosclerosis is largely unknown. We hypothesize that lysine-specific demethylase 1A ( ... ...

    Abstract Dysregulated epigenetic mechanisms promote transcriptomic and phenotypic alterations in cardiovascular diseases. The role of histone methylation-related pathways in atherosclerosis is largely unknown. We hypothesize that lysine-specific demethylase 1A (LSD1/KDM1A) regulates key molecular effectors and pathways linked to atherosclerotic plaque formation. Human non-atherosclerotic and atherosclerotic tissue specimens, ApoE-/- mice, and in vitro polarized macrophages (Mac) were examined. Male ApoE-/- mice fed a normal/atherogenic diet were randomized to receive GSK2879552, a highly specific LSD1 inhibitor, or its vehicle, for 4 weeks. The mRNA and protein expression levels of LSD1/KDM1A were significantly elevated in atherosclerotic human carotid arteries, atherosclerotic aortas of ApoE-/- mice, and M1-Mac. Treatment of ApoE-/- mice with GSK2879552 significantly reduced the extent of atherosclerotic lesions and the aortic expression of NADPH oxidase subunits (Nox1/2/4, p22phox) and 4-hydroxynonenal-protein adducts. Concomitantly, the markers of immune cell infiltration and vascular inflammation were significantly decreased. LSD1 blockade down-regulated the expression of genes associated with Mac pro-inflammatory phenotype. Nox subunit transcript levels were significantly elevated in HEK293 reporter cells overexpressing LSD1. In experimental atherosclerosis, LSD1 mediates the up-regulation of molecular effectors connected to oxidative stress and inflammation. Together, these data indicate that LSD1-pharmacological interventions are novel targets for supportive therapeutic strategies in atherosclerosis.
    Sprache Englisch
    Erscheinungsdatum 2022-12-01
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox11122382
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel: Synthetic lipoproteins based on apolipoprotein E coupled to fullerenol have anti-atherosclerotic properties.

    Tudorache, Irina Florina / Bivol, Violeta Georgeta / Dumitrescu, Madalina / Fenyo, Ioana Madalina / Simionescu, Maya / Gafencu, Anca Violeta

    Pharmacological reports : PR

    2022  Band 74, Heft 4, Seite(n) 684–695

    Abstract: Background: Apolipoprotein E (apoE) is an anti-atherosclerotic protein associated with almost all plasma lipoproteins. Fullerenol (Full-OH) contains the fullerene hydrophobic cage and several hydroxyl groups that could be derivatized to covalently bind ... ...

    Abstract Background: Apolipoprotein E (apoE) is an anti-atherosclerotic protein associated with almost all plasma lipoproteins. Fullerenol (Full-OH) contains the fullerene hydrophobic cage and several hydroxyl groups that could be derivatized to covalently bind various molecules. Herein, we aimed to produce fullerenol-based nanoparticles carrying apoE3 (Full-apoE) and test their anti-atherosclerotic effects.
    Methods: Full-apoE nanoparticles were obtained from Full-OH activated to reactive cyanide ester fullerenol derivative that was further reacted with apoE protein. To test their effect, the nanoparticles were administered to apoE-deficient mice for 24 h or 3 weeks. ApoE part of the nanoparticles was determined by Western Blot and quantified by ELISA. Atherosclerotic plaque size was evaluated after Oil Red O staining and the gene expression was determined by Real-Time PCR.
    Results: Full-apoE nanoparticles were detected mainly in the liver, and to a lesser extent in the kidney, lung, and brain. In the plasma of the Full-apoE-treated mice, apoE was found associated with very-low-density lipoproteins and high-density lipoproteins. Treatment for 3 weeks with Full-apoE nanoparticles decreased plasma cholesterol levels, increased the expression of apolipoprotein A-I, ABCA1 transporter, scavenger receptor-B1, and sortilin, and reduced the evolution of the atheromatous plaques in the atherosclerotic mice.
    Conclusions: In experimental atherosclerosis, the administration of Full-apoE nanoparticles limits the evolution of the atheromatous plaques by decreasing the plasma cholesterol level and increasing the expression of major proteins involved in lipid metabolism. Thus, they represent a novel promising strategy for atherosclerosis therapy.
    Mesh-Begriff(e) Animals ; Apolipoproteins E/genetics ; Atherosclerosis/drug therapy ; Cholesterol ; Fullerenes/pharmacology ; Fullerenes/therapeutic use ; Mice ; Mice, Knockout ; Plaque, Atherosclerotic/drug therapy
    Chemische Substanzen Apolipoproteins E ; Fullerenes ; fullerenol (182024-42-6) ; Cholesterol (97C5T2UQ7J)
    Sprache Englisch
    Erscheinungsdatum 2022-07-05
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2186248-5
    ISSN 1734-1140
    ISSN 1734-1140
    DOI 10.1007/s43440-022-00379-8
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel: Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease.

    Fuior, Elena Valeria / Zvintzou, Evangelia / Filippatos, Theodosios / Giannatou, Katerina / Mparnia, Victoria / Simionescu, Maya / Gafencu, Anca Violeta / Kypreos, Kyriakos E

    Biomedicines

    2023  Band 11, Heft 10

    Abstract: Peroxisome proliferator-activated receptors (PPARs) are a group of ligand-binding transcription factors with pivotal action in regulating pleiotropic signaling pathways of energetic metabolism, immune responses and cell proliferation and differentiation. ...

    Abstract Peroxisome proliferator-activated receptors (PPARs) are a group of ligand-binding transcription factors with pivotal action in regulating pleiotropic signaling pathways of energetic metabolism, immune responses and cell proliferation and differentiation. A significant body of evidence indicates that the PPARα receptor is an important modulator of plasma lipid and lipoprotein metabolism, with pluripotent effects influencing the lipid and apolipoprotein cargo of both atherogenic and antiatherogenic lipoproteins and their functionality. Clinical evidence supports an important role of PPARα agonists (fibric acid derivatives) in the treatment of hypertriglyceridemia and/or low high-density lipoprotein (HDL) cholesterol levels, although the effects of clinical trials are contradictory and point to a reduction in the risk of nonfatal and fatal myocardial infarction events. In this manuscript, we provide an up-to-date critical review of the existing relevant literature.
    Sprache Englisch
    Erscheinungsdatum 2023-10-03
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines11102696
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel: Activated Histone Acetyltransferase p300/CBP-Related Signalling Pathways Mediate Up-Regulation of NADPH Oxidase, Inflammation, and Fibrosis in Diabetic Kidney

    Lazar, Alexandra-Gela / Vlad, Mihaela-Loredana / Manea, Adrian / Simionescu, Maya / Manea, Simona-Adriana

    Antioxidants. 2021 Aug. 26, v. 10, no. 9

    2021  

    Abstract: Accumulating evidence implicates the histone acetylation-based epigenetic mechanisms in the pathoetiology of diabetes-associated micro-/macrovascular complications. Diabetic kidney disease (DKD) is a progressive chronic inflammatory microvascular ... ...

    Abstract Accumulating evidence implicates the histone acetylation-based epigenetic mechanisms in the pathoetiology of diabetes-associated micro-/macrovascular complications. Diabetic kidney disease (DKD) is a progressive chronic inflammatory microvascular disorder ultimately leading to glomerulosclerosis and kidney failure. We hypothesized that histone acetyltransferase p300/CBP may be involved in mediating diabetes-accelerated renal damage. In this study, we aimed at investigating the potential role of p300/CBP in the up-regulation of renal NADPH oxidase (Nox), reactive oxygen species (ROS) production, inflammation, and fibrosis in diabetic mice. Diabetic C57BL/6J mice were randomized to receive 10 mg/kg C646, a selective p300/CBP inhibitor, or its vehicle for 4 weeks. We found that in the kidney of C646-treated diabetic mice, the level of H3K27ac, an epigenetic mark of active gene expression, was significantly reduced. Pharmacological inhibition of p300/CBP significantly down-regulated the diabetes-induced enhanced expression of Nox subtypes, pro-inflammatory, and pro-fibrotic molecules in the kidney of mice, and the glomerular ROS overproduction. Our study provides evidence that the activation of p300/CBP enhances ROS production, potentially generated by up-regulated Nox, inflammation, and the production of extracellular matrix proteins in the diabetic kidney. The data suggest that p300/CBP-pharmacological inhibitors may be attractive tools to modulate diabetes-associated pathological processes to efficiently reduce the burden of DKD.
    Schlagwörter NAD(P)H oxidase (H2O2-forming) ; epigenetics ; extracellular matrix ; fibrosis ; gene expression ; histone acetyltransferase ; histones ; inflammation ; kidneys ; reactive oxygen species ; renal failure
    Sprache Englisch
    Erscheinungsverlauf 2021-0826
    Erscheinungsort Multidisciplinary Digital Publishing Institute
    Dokumenttyp Artikel
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox10091356
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang